[ad_1] STOCKHOLM, Dec. 5, 2025 /PRNewswire/ — Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) (“SciBase” or the “Company“). The general meeting resolved in accordance with the proposal presented in […]
Tag: SciBase
Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2026
[ad_1] STOCKHOLM, Oct. 22, 2025 /PRNewswire/ — The following people have been appointed as members of SciBase Holding’s nominating committee for the Annual General Meeting in 2026: Anders Bladh (Ribbskottet AB), Derek Maetzold (Castle Biosciences Inc) […]
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot
[ad_1] STOCKHOLM, Jan. 3, 2025 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it is working with Mayo Clinic, the leading US […]
SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient
[ad_1] STOCKHOLM, Nov. 13, 2024 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the publication of a case study highlighting the use of […]
Notice to extraordinary general meeting in Scibase Holding AB (publ)
[ad_1] STOCKHOLM, Nov. 12, 2024 /PRNewswire/ — Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the “Company“), are hereby summoned to an extraordinary general meeting to be held on 13 December 2024 at 10.00 […]
